Results 1 to 10 of about 8,006 (176)

Transjugular intrahepatic porto systemic shunt

The Turkish Journal of Gastroenterology, 1999
The Transjugular Intrahepatic Portosystemic Shunt (TIPS) has now become an accepted part of the therapeutic armory available to the practicing clinician. It may stop variceal bleeding when traditional endoscopic techniques have failed, and can be used as secondary prevention of variceal bleeding, as well as a treatment for intractable ascites and the ...
Yurtkuran SADIKOĞLU, Selim Giray NAK, Ercan TUNCEL, Faruk MEMİK   +3 more
doaj   +3 more sources

First Report of Fulminant Budd-Chiari Syndrome Treated by Direct Intrahepatic Portocaval Shunt in Vietnam

Case Reports in Gastroenterology, 2021
Budd-Chiari syndrome (BCS) is a rare disorder caused by hepatic venous outflow obstruction that can lead to acute liver failure proposing liver transplantation or transjugular intrahepatic portosystemic shunt.
Thai Van Nguyen, Thinh Tien Nguyen, Hoang Duc Dong, Huy Quang Duong   +3 more
doaj   +1 more source

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Hepatology, EarlyView., 2022
The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck, Louise Schwierz, Wenyi Gu, Philip G. Ferstl, Christian Jansen, Frank E. Uschner, Michael Praktiknjo, Johannes Chang, Maximilian J. Brol, Filippo Schepis, Manuela Merli, Christian P. Strassburg, Jennifer Lehmann, Carsten Meyer, Jonel Trebicka   +14 more
wiley   +1 more source

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Hepatology, EarlyView., 2022
Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres, Cristina Ortiz, Nadine Bachtler, Wenyi Gu, Leon D. Grünewald, Nico Kraus, Robert Schierwagen, Christoph Hieber, Caroline Meier, Olaf Tyc, Maximilian Joseph Brol, Frank Erhard Uschner, Bart Nijmeijer, Christoph Welsch, Marie‐Luise Berres, Carmen Garcia‐Ruiz, Jose Carlos Fernandez‐Checa, Christian Trautwein, Thomas J. Vogl, Stefan Zeuzem, Jonel Trebicka, Sabine Klein   +21 more
wiley   +1 more source

Transjugular Intrahepatic Portosystemic Shunt [PDF]

Clinics in Liver Disease, 2014
Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for the complications of portal hypertension. The largest body of evidence for its use has been supported for recurrent or refractory variceal bleeding and refractory ascites.
Kavish R, Patidar, Malcolm, Sydnor, Arun J, Sanyal   +2 more
openaire   +2 more sources

A rare case of severe tricuspid regurgitation caused by detached stent falling into the right ventricle after transjugular intrahepatic portosystemic shunt

Journal of Cardiothoracic Surgery, 2022
Background Transjugular intrahepatic portosystemic shunt (TIPS) is an important method to alleviate cirrhotic portal hypertension. But the falling and fracture of the stent which detaches into the heart is a potentially fatal threat. Case presentation We
Feng Xiong, Kunyue Tan, Lijian Cheng, Yong Luo, Zhengkai Zhao   +4 more
doaj   +1 more source

MesoTIPS: Combined Approach for the Treatment of Portal Hypertension Secondary to Portal Vein Thrombosis – A Brief Report

The Arab Journal of Interventional Radiology, 2017
Introduction: We describe a technique we call “Meso-transjugular intrahepatic portosystemic shunt (MTIPS)” for relief of portal hypertension secondary to portal vein thrombosis (PVT) using combined surgical and endovascular technique.
Abbas Chamsuddin, Lama Nazzal, Thomas Heffron, Osama Gaber, Raja Achou, Louis G. Martin   +5 more
doaj   +3 more sources

Preliminary clinical observation of double C-arm digital subtraction angiography guidance during transjugular intrahepatic portosystemic shunt placement

BMC Gastroenterology, 2023
Background This study aimed to investigate the safety, preliminary clinical experience, and technical advantages of double C-arm digital subtraction angiography -assisted portal vein puncture for transjugular intrahepatic portosystemic shunt.
Jianqiao Chen, Xiao Bai, Chunyan Wang, Jihua Li, Weiguo Xu   +4 more
doaj   +1 more source

Technical and Medium-Term Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Fluoroscopy and Additional Trans-abdominal Ultrasound Guidance

Indian Journal of Radiology and Imaging, 2021
Background and Objective The aim of the study is to evaluate the technical and clinical outcomes of transjugular intrahepatic portosystemic shunt (TIPS) performed with additional transabdominal ultrasound guidance.
Shyamkumar N. Keshava, Vinu Moses, Anand Sharma, Munawwar Ahmed, Sathya Narayanan, Aswin Padmanabhan, Ashish Goel, Uday Zachariah, C.E. Eapen   +8 more
doaj   +1 more source